WHO ICTRP trial
Evaluation of Glucose Tolerance in Radioiodine Treated Thyroid Carcinoma Patient
TCTR20180601003 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20180601003 |
|---|---|
| Public title | Evaluation of Glucose Tolerance in Radioiodine Treated Thyroid Carcinoma Patient |
| Scientific title | Evaluation of Glucose Tolerance in Radioiodine Treated Thyroid Carcinoma Patient: A prospective cohort study |
| Primary sponsor | Ratchadapiseksompotch Fund, Faculty of Medicine |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Countries | Thailand |
| Conditions | thyroid carcinoma treated with radioactive iodine radioactive iodine glucose tolerance thyroid carcinoma;radioactive iodine glucose tolerance thyroid carcinoma |
| Interventions | The Thyroid cancer patient who will undogo treat with high dose (>100 millicurie) radioactive iodine;Screening;Radioactive iodine treated thyroid cancer |
| Registration date | Jan 6, 2018 |
| Target size | 20 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: